Ligand Pharmaceuticals, Inc.
S&P 600
$284.47
-1.65%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 8.7 times.
- Return on equity is moderate at 12.9%.
- Net profit margin is strong at 46.4%.
- Current assets comfortably cover current liabilities (current ratio 22.23).
!Watch-points
- Return on capital employed is on the lower side at 1.9%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
7.79
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
4 / 6
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 6 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$5.67B
Current Price$ 284.47
High / Low$ 326.63 / 161.82
Stock P/E29.326805
Book Value$ 44.31
Dividend Yield0%
ROCE1.91%
ROE12.86%
Current Ratio22.23
P/B Ratio5.856908
EPS$ 6.13
PAT Margin46.42%
Cash PAT$158.23M
ICR8.70